The Synthesis of Azasugars Using an I2-mediated Carbamate Annulation

<p>The biological activity of azasugars has largely been attributed to their ability to mimic the oxocarbenium ion-like transition state formed during reactions with carbohydrate-processing enzymes and, for this reason, functional and stereochemical modifications of the azasugar scaffold have led to the development of specific and potent glycosidase inhibitors. Given the potential of azasugars as glycosidase inhibitors, we were interested in developing efficient methodology for their synthesis. This thesis highlights synthetic methodology developed to produce amino-imino-hexitols as azasugar scaffolds. Key in the synthesis of the amino-imino-hexitols was the application of a stereoselective Strecker reaction, without the need for chiral Lewis acids or catalysts, and an extension of an I2-mediated carbamate annulation to cyclise functionalised and protected alkenylamines. Sixteen amino-imino-hexitols were synthesized, including ten previously undisclosed substrates with the D-galacto, D-talo, and L-altro configurations. The novel amino-imino-hexitols were then tested for their ability to act as glycosidase inhibitors and substrates of the D-talo configuration showed promising inhibitory effects. Mechanistic considerations of the I2-mediated carbamate annulation are discussed and although the exact annulation mechanism has yet to be determined, experimental studies have revealed that an aziridine is not an intermediate in the reaction. Factors influencing the diastereoselectivity of the carbamate annulation are also explored. Furthermore, an in depth analysis of the high cis-selectivity of the carbamate annulation is investigated using density functional theory to calculate the transition states of iodocyclisations en route to the formation of carbamates. Taken as a whole, the applicability of the carbamate annulation to a variety of alkenylamines and an understanding of the factors controlling the diastereoselectivity of the reaction should make this methodology a valuable addition to the synthetic chemist’s toolbox.</p>

Synthesis of N-Glycans and Azasugars to Target Disease

<p>In this thesis two aspects of carbohydrate research will be discussed. First, the total synthesis of N-glycans found on allergens that are known to stimulate an allergic immune response and second, the synthesis of iminosugars in an attempt to extend the scope of the PGF-methodology. Asthma affects 235 million people worldwide, with New Zealand ranking among the highest in the world. Although there is a good understanding of how allergens trigger the immune system on a “macroscopic” level, how an allergen’s molecular structure causes such an allergic response remains unknown. Upon close review of carbohydrates present on the allergens that are known to give an allergic T helper (Th 2) immune response, a common structure has been identified. The structure consists of a complex type N-glycan made up of a pentasaccharide core (Man3(GlcNHAc)2), with additional 1,3-linked α-L-fucose and 1,2-linked D-xylose cappings. As part of a structure relationship study this heptasaccharide and structural derivatives thereof have been synthesised. The synthesis of these N-glycans will allow a more detailed study of the role of these defined structures in triggering an allergic immune response. The second part of this thesis focuses on the protecting group free (PGF) synthesis of iminosugars, which are potent glycosidase inhibitors and are currently used in the treatment of a variety of diseases. Synthetic strategies for the synthesis of iminosugars involve the use of protecting groups, which are necessary to block potential competing reactive centres within a molecule during the multistep synthesis. The disadvantage, however, is that the installation of protecting groups introduces additional steps to the total synthesis, which inevitably leads to lower yields and the generation of waste. Within our group, PGF methodologies have been developed which allow for the synthesis of a variety of iminosugars. The work presented in this thesis extends the scope of this methodology for the synthesis of an important class of iminosugars, the 2,5-dihydroxymethyl-3,4-dihydroxypyrrolidines. For the purpose of introducing an additional hydroxymethyl group, a ketose starting material was required, and therefore an efficient Vasella/reductive amination reaction using ketoses was developed. Additionally, iodocyclisation and carbamate annulation of the intermediate alkenylamines provided successful entry to the 2,5-dihydroxymethyl-3,4-dihydroxypyrrolidines, exemplified by the efficient 6-step synthesis of 2,5-dideoxy-2,5-imino-L-iditol and 2,5-dideoxy-2,5-imino-D-mannitol (DMDP).</p>

The Synthesis of Azasugars Using an I2-mediated Carbamate Annulation

<p>The biological activity of azasugars has largely been attributed to their ability to mimic the oxocarbenium ion-like transition state formed during reactions with carbohydrate-processing enzymes and, for this reason, functional and stereochemical modifications of the azasugar scaffold have led to the development of specific and potent glycosidase inhibitors. Given the potential of azasugars as glycosidase inhibitors, we were interested in developing efficient methodology for their synthesis. This thesis highlights synthetic methodology developed to produce amino-imino-hexitols as azasugar scaffolds. Key in the synthesis of the amino-imino-hexitols was the application of a stereoselective Strecker reaction, without the need for chiral Lewis acids or catalysts, and an extension of an I2-mediated carbamate annulation to cyclise functionalised and protected alkenylamines. Sixteen amino-imino-hexitols were synthesized, including ten previously undisclosed substrates with the D-galacto, D-talo, and L-altro configurations. The novel amino-imino-hexitols were then tested for their ability to act as glycosidase inhibitors and substrates of the D-talo configuration showed promising inhibitory effects. Mechanistic considerations of the I2-mediated carbamate annulation are discussed and although the exact annulation mechanism has yet to be determined, experimental studies have revealed that an aziridine is not an intermediate in the reaction. Factors influencing the diastereoselectivity of the carbamate annulation are also explored. Furthermore, an in depth analysis of the high cis-selectivity of the carbamate annulation is investigated using density functional theory to calculate the transition states of iodocyclisations en route to the formation of carbamates. Taken as a whole, the applicability of the carbamate annulation to a variety of alkenylamines and an understanding of the factors controlling the diastereoselectivity of the reaction should make this methodology a valuable addition to the synthetic chemist’s toolbox.</p>

Synthesis of N-Glycans and Azasugars to Target Disease

<p>In this thesis two aspects of carbohydrate research will be discussed. First, the total synthesis of N-glycans found on allergens that are known to stimulate an allergic immune response and second, the synthesis of iminosugars in an attempt to extend the scope of the PGF-methodology. Asthma affects 235 million people worldwide, with New Zealand ranking among the highest in the world. Although there is a good understanding of how allergens trigger the immune system on a “macroscopic” level, how an allergen’s molecular structure causes such an allergic response remains unknown. Upon close review of carbohydrates present on the allergens that are known to give an allergic T helper (Th 2) immune response, a common structure has been identified. The structure consists of a complex type N-glycan made up of a pentasaccharide core (Man3(GlcNHAc)2), with additional 1,3-linked α-L-fucose and 1,2-linked D-xylose cappings. As part of a structure relationship study this heptasaccharide and structural derivatives thereof have been synthesised. The synthesis of these N-glycans will allow a more detailed study of the role of these defined structures in triggering an allergic immune response. The second part of this thesis focuses on the protecting group free (PGF) synthesis of iminosugars, which are potent glycosidase inhibitors and are currently used in the treatment of a variety of diseases. Synthetic strategies for the synthesis of iminosugars involve the use of protecting groups, which are necessary to block potential competing reactive centres within a molecule during the multistep synthesis. The disadvantage, however, is that the installation of protecting groups introduces additional steps to the total synthesis, which inevitably leads to lower yields and the generation of waste. Within our group, PGF methodologies have been developed which allow for the synthesis of a variety of iminosugars. The work presented in this thesis extends the scope of this methodology for the synthesis of an important class of iminosugars, the 2,5-dihydroxymethyl-3,4-dihydroxypyrrolidines. For the purpose of introducing an additional hydroxymethyl group, a ketose starting material was required, and therefore an efficient Vasella/reductive amination reaction using ketoses was developed. Additionally, iodocyclisation and carbamate annulation of the intermediate alkenylamines provided successful entry to the 2,5-dihydroxymethyl-3,4-dihydroxypyrrolidines, exemplified by the efficient 6-step synthesis of 2,5-dideoxy-2,5-imino-L-iditol and 2,5-dideoxy-2,5-imino-D-mannitol (DMDP).</p>

The Synthesis of Carbohydrates for the Treatment of Disease

<p>In this thesis I investigated two aspects of glycobiology. In the first, I investigated the potential of α-GalCer analogues to be used in cancer immunotherapy. Two 4-deoxy α-GalCer analogues, with either a sphinganine or a sphingosine base, were synthesised using a convergent strategy. The α-GalCer sphinganine derivative was synthesised in 14 steps from D-arabinose, and in an overall 13% yield. The α-GalCer sphingosine analogue was synthesised in 13 steps also in 13% yield. Biological analysis revealed that both 4-deoxy analogues possessed comparable activity to α-GalCer in mice, however demonstrated significantly reduced hNKT cell activity. The reduced activity was attributed to species-specific differences in iNKT cell glycolipid recognition rather than reduced CD1d presentation. From these results we suggest that glycolipids developed for potent CD1d-iNKT cell activity in humans should contain a ceramide base with the 4-hydroxyl present. The second part of this thesis focused on protecting group free methodology for the synthesis of sugar mimetics that have proven potential as glycosidase inhibitors. In this work I developed an efficient, high yielding and diastereoselective strategy for the synthesis of a number of five and six membered azasugars. This strategy utilises two novel reaction methodologies. The first enabled the stereoselective formation of cyclic carbamates from olefinic amines, the transition states controlling the stereoselectivity during this reaction are discussed. The second reaction facilitated the synthesis of primary amines without the need for protecting groups, the scope of this reductive amination methodology is also investigated. The five membered azasugars 1,4-dideoxy-1,4-imino-Dxylitol, 1,4-dideoxy-1,4-imino-L-lyxitol, 1,4-dideoxy-1,4-imino-L-xylitol and 1,2,4-trideoxy-1,4-imino-L-xylitol were prepared in 5 steps, in good overall yields (57%, 55%, 54% and 48% respectively), and without the need for protecting groups. The six membered azasugar DGJ was prepared over six steps in 33% yield using similar methodology. The synthesised compounds were also tested for anti-tubercular activity using a BCG alamar blue assay.</p>

The Synthesis of Carbohydrates for the Treatment of Disease

<p>In this thesis I investigated two aspects of glycobiology. In the first, I investigated the potential of α-GalCer analogues to be used in cancer immunotherapy. Two 4-deoxy α-GalCer analogues, with either a sphinganine or a sphingosine base, were synthesised using a convergent strategy. The α-GalCer sphinganine derivative was synthesised in 14 steps from D-arabinose, and in an overall 13% yield. The α-GalCer sphingosine analogue was synthesised in 13 steps also in 13% yield. Biological analysis revealed that both 4-deoxy analogues possessed comparable activity to α-GalCer in mice, however demonstrated significantly reduced hNKT cell activity. The reduced activity was attributed to species-specific differences in iNKT cell glycolipid recognition rather than reduced CD1d presentation. From these results we suggest that glycolipids developed for potent CD1d-iNKT cell activity in humans should contain a ceramide base with the 4-hydroxyl present. The second part of this thesis focused on protecting group free methodology for the synthesis of sugar mimetics that have proven potential as glycosidase inhibitors. In this work I developed an efficient, high yielding and diastereoselective strategy for the synthesis of a number of five and six membered azasugars. This strategy utilises two novel reaction methodologies. The first enabled the stereoselective formation of cyclic carbamates from olefinic amines, the transition states controlling the stereoselectivity during this reaction are discussed. The second reaction facilitated the synthesis of primary amines without the need for protecting groups, the scope of this reductive amination methodology is also investigated. The five membered azasugars 1,4-dideoxy-1,4-imino-Dxylitol, 1,4-dideoxy-1,4-imino-L-lyxitol, 1,4-dideoxy-1,4-imino-L-xylitol and 1,2,4-trideoxy-1,4-imino-L-xylitol were prepared in 5 steps, in good overall yields (57%, 55%, 54% and 48% respectively), and without the need for protecting groups. The six membered azasugar DGJ was prepared over six steps in 33% yield using similar methodology. The synthesised compounds were also tested for anti-tubercular activity using a BCG alamar blue assay.</p>

Comparative genomic analysis of azasugar biosynthesis

Azasugars are monosaccharide analogs in which the ring oxygen is replaced with a nitrogen atom. These well-known glycosidase inhibitors are of interest as therapeutics, yet several aspects of azasugars remain unknown including their distribution, structural diversity, and chemical ecology. The hallmark signature of bacterial azasugar biosynthesis is a three gene cluster (3GC) coding for aminotransferase, phosphatase, and dehydrogenase enzymes. Using the bioinformatics platform Enzyme Similarity Tool (EST), we identified hundreds of putative three gene clusters coding for azasugar production in microbial species. In the course of this work, we also report a consensus sequence for the aminotransferase involved in azasugar biosynthesis as being: SGNXFRXXXFPNXXXXXXXLXVPXPYCXRC. Most clusters are found in Bacillus and Streptomyces species which typically inhabit soil and the rhizosphere, but some clusters are found with diverse species representation such as Photorhabdus and Xenorhabdus which are symbiotic with entomopathogenic nematodes; the human skin commensal Cutibacterium acnes, and the marine Bacillus rugosus SPB7, a symbiont to the sea sponge Spongia officinalis. This pan-taxonomic survey of the azasugar 3GC signature may lead to the identification of new azasugar producers, facilitate studies of their natural functions, and lead to new potential therapeutics.